Pinealon

Pinealon is a synthetic tripeptide (Glu-Asp-Arg) developed by Vladimir Khavinson's group at the St. Petersburg Institute of Bioregulation and Gerontology — the same group behind Epithalon and Cartalax. While Epithalon was derived from the pineal peptide fraction Epiphamine, Pinealon was developed specifically as a neuroprotective peptide bioregulator. Preclinical research suggests it may penetrate the blood-brain barrier and exert neuroprotective effects in oxidative stress and hypoxia models. Studies from the Khavinson group report benefits in cognitive aging, hypoxic brain injury models, and circadian rhythm-related decline. Like other Khavinson bioregulators, the evidence base is almost entirely from the originating research group and has not been independently replicated.

Reconstitution

Reconstitute with bacteriostatic water. Store refrigerated. Use within 30 days.